 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 2003, 23(7):2735
Inhibition of Bax-Induced Cytochrome c Release
from Neural Cell and Brain Mitochondria by Dibucaine and
Propranolol
Brian M.
Polster1, 2,
Gorka
Basañez3,
Michael
Young1,
Motoshi
Suzuki4, and
Gary
Fiskum1
1 Department of Anesthesiology and
2 Neuroscience Program, University of Maryland
School of Medicine, Baltimore, Maryland 21201, 3 Unidad
de Biofísica (Centro Mixto Consejo Superior de Investigaciones
Científicas-Universidad del País Vasco/Euskal Herriko
Unibertsitatea) y Departamento de Bioquímica y
Biología Molecular, Universidad del País Vasco, 48080 Bilbao, Spain, and 4 Biochemistry Section, Surgical
Neurology Branch, National Institute of Neurological Disorders and
Stroke, National Institutes of Health, Bethesda, Maryland 20892
BH3 (Bcl-2 homology 3)-only proteins of the Bcl-2 family
activate Bax or Bak during apoptosis to promote the release of
pro-death factors sequestered in the mitochondrial intermembrane
space. Previous results demonstrated that a synthetic BH3 peptide
mimics the ability of the BH3-only protein Bid to promote Bax insertion and cytochrome c (cyt c) release from
neural cell mitochondria. However, the BH3 peptide was deficient in
promoting cyt c release from mitochondria without
associated Bax, such as adult rat brain mitochondria. This study tested
the hypothesis that the amphiphilic membrane-active cationic drugs
dibucaine and propranolol block BH3 peptide-initiated cyt
c efflux by preventing the integration of Bax into the
mitochondrial outer membrane. BH3 peptide-initiated release of cyt
c from GT1-7 neural cell mitochondria was inhibited by
dibucaine and propranolol at concentrations of 100-300
µM. Recombinant Bax (100 nM) alone did not
release cyt c from adult rat brain mitochondria;
however, when BH3 peptide or caspase-8 cleaved Bid (cBid) was added,
robust cyt c release was achieved that was inhibited
completely by 200 µM dibucaine or propranolol. These
drugs at similar concentrations also inhibited release of entrapped 10 kDa dextrans from protein-free liposomes treated with Bax and cBid.
Contrary to the hypothesis that dibucaine and propranolol act by
inhibiting the insertion of Bax into the mitochondrial outer membrane,
membrane insertion of Bax was not inhibited in mitochondria or
liposomes, indicating a mechanism of drug action downstream from this
event. These results suggest that dibucaine and propranolol inhibit
Bax-induced permeability changes through a direct interaction with the
lipid membrane and present a novel target for the development of
neuroprotective, antiapoptotic therapeutics.
Key words:
Bax; BH3; Bid; brain mitochondria; cytochrome
c; dibucaine; propranolol; apoptosis; permeability
transition
Copyright © 2003 Society for Neuroscience 0270-6474/03/2372735-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
O. Terrones, A. Etxebarria, A. Landajuela, O. Landeta, B. Antonsson, and G. Basanez
BIM and tBID Are Not Mechanistically Equivalent When Assisting BAX to Permeabilize Bilayer Membranes
J. Biol. Chem.,
March 21, 2008;
283(12):
7790 - 7803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev,
January 1, 2007;
87(1):
99 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Dejean, S. Martinez-Caballero, L. Guo, C. Hughes, O. Teijido, T. Ducret, F. Ichas, S. J. Korsmeyer, B. Antonsson, E. A. Jonas, et al.
Oligomeric Bax Is a Component of the Putative Cytochrome c Release Channel MAC, Mitochondrial Apoptosis-induced Channel
Mol. Biol. Cell,
May 1, 2005;
16(5):
2424 - 2432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Polster, G. Basanez, A. Etxebarria, J. M. Hardwick, and D. G. Nicholls
Calpain I Induces Cleavage and Release of Apoptosis-inducing Factor from Isolated Mitochondria
J. Biol. Chem.,
February 25, 2005;
280(8):
6447 - 6454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. De Marchi, S. Campello, I. Szabo, F. Tombola, J.-C. Martinou, and M. Zoratti
Bax Does Not Directly Participate in the Ca2+-induced Permeability Transition of Isolated Mitochondria
J. Biol. Chem.,
September 3, 2004;
279(36):
37415 - 37422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Green and G. Kroemer
The Pathophysiology of Mitochondrial Cell Death
Science,
July 30, 2004;
305(5684):
626 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Terrones, B. Antonsson, H. Yamaguchi, H.-G. Wang, J. Liu, R. M. Lee, A. Herrmann, and G. Basanez
Lipidic Pore Formation by the Concerted Action of Proapoptotic BAX and tBID
J. Biol. Chem.,
July 16, 2004;
279(29):
30081 - 30091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Rostovtseva, B. Antonsson, M. Suzuki, R. J. Youle, M. Colombini, and S. M. Bezrukov
Bid, but Not Bax, Regulates VDAC Channels
J. Biol. Chem.,
April 2, 2004;
279(14):
13575 - 13583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Yethon, R. F. Epand, B. Leber, R. M. Epand, and D. W. Andrews
Interaction with a Membrane Surface Triggers a Reversible Conformational Change in Bax Normally Associated with Induction of Apoptosis
J. Biol. Chem.,
December 5, 2003;
278(49):
48935 - 48941.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|